<?xml version="1.0" encoding="UTF-8"?>        <rss version="2.0"
             xmlns:atom="http://www.w3.org/2005/Atom"
             xmlns:dc="http://purl.org/dc/elements/1.1/"
             xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
             xmlns:admin="http://webns.net/mvcb/"
             xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
             xmlns:content="http://purl.org/rss/1.0/modules/content/">
        <channel>
            <title>
									300K Solutions Foro - Recent Posts				            </title>
            <link>https://300k.bio/community/</link>
            <description>300K Solutions General</description>
            <language>en-US</language>
            <lastBuildDate>Fri, 12 Jun 2026 23:09:13 +0000</lastBuildDate>
            <generator>wpForo</generator>
            <ttl>60</ttl>
							                    <item>
                        <title>Liquid biopsy using dried plasma samples: would this work in your workflow?</title>
                        <link>https://300k.bio/community/suggestions/liquid-biopsy-using-dried-plasma-samples-would-this-work-in-your-workflow/#post-3</link>
                        <pubDate>Tue, 07 Apr 2026 11:14:31 +0000</pubDate>
                        <description><![CDATA[Liquid biopsy has opened the door to diagnosing and monitoring solid tumors using liquid samples  instead of traditional tissue biopsies. In these workflows, circulating DNA (ctDNA/cfDNA) ex...]]></description>
                        <content:encoded><![CDATA[<p>Liquid biopsy has opened the door to diagnosing and monitoring solid tumors using liquid samples  instead of traditional tissue biopsies. In these workflows, circulating DNA (ctDNA/cfDNA) extracted from plasma is typically analyzed using techniques such as digital PCR or NGS. The advantages over invasive tissue biopsies are well known: lower risk, repeatability, and easier patient follow‑up. However, one of the main limitations in real workflows is still pre‑analytical handling: sample stability, logistics, and standardization often become bottlenecks.</p>
<div>
<div>With 300K’s plasma stabilization technology, circulating DNA can be preserved with purity and integrity comparable to frozen samples, without relying on cold‑chain conditions.</div>
<div> </div>
</div>
<div>If you work with liquid biopsy, how would this fit into your day‑to‑day practice? Would freeze-dried plasma samples work in your current workflow?</div>]]></content:encoded>
						                            <category domain="https://300k.bio/community/"></category>                        <dc:creator>300K Team</dc:creator>
                        <guid isPermaLink="true">https://300k.bio/community/suggestions/liquid-biopsy-using-dried-plasma-samples-would-this-work-in-your-workflow/#post-3</guid>
                    </item>
							        </channel>
        </rss>
		